Fangda Partners is a leading firm in the capital markets arena which is widely recognised for its experience in complex, high-profile A-share IPOs, material assets restructurings and public M&A. The firm boasts a strong client base in a variety of sectors, including TMT, healthcare and biotech. In addition to equity, the firm has a strong team which covers the full range of debt securities offerings and related transactions. Leo Lou leads the equity capital markets team in Shanghai, while Xueyan Jiang, Christine Chen and Dong Wu lead the Beijing equity capital markets team, the debt capital markets practice and the asset-backed securities teams, respectively. Jeffrey Ding, who has significant experience of advising international clients, and Michael Qi are also important partners to note, while counsel Helen Zhao provides key support in cross-border matters.
Testimonials
Collated independently by Legal 500 research team.
- ‘The Fangda Partners capital markets team is very professional in the industry and can provide customers with quality services.’
- ‘The team structure is reasonable, and the team members have excellent business, language, and communication skills.'
- ‘Christine Chen has extensive experience in this field and has assisted our company in completing cutting-edge bond issuance projects. In this project, Chen and her team showed their ability to handle and grasp cutting-edge legal issues and innovative transaction structures.'
- ‘Professional, cost-effective, and highly cooperative.’
Key clients
- InnoCare Pharma Limited
- Motorcomm Electronic Technology Co., Ltd.
- Hi-trend Technology
- Horizon Construction Development Limited
- Jiangsu Huachen Transformer Co., Ltd.
- KRP Development Holdings Limited
- Kingsoft Cloud
- Asian Infrastructure Investment Bank
- Deutsche Bank Aktiengesellschaft
- Hungary (represented by Government Debt Management Agency Private Company Limited by Shares)
- BMW China Capital B.V.
- BMW AG
- China International Capital Co., Ltd.
- CITIC Securities Co., Ltd.
Work highlights
- Advised InnoCare Pharma Limited on its successful listing on the Shanghai Stock Exchange’s STAR Market, raising a total of about RMB2.9 billion.
- Advised Asian Infrastructure Investment Bank on its first sustainable development bond issuance in China.
- Advised CITIC Securities Co., Ltd. on the first phase of CITIC Goldstone-China Resources Land Wanxiang C-REIT.
Lawyers
Practice head
The lawyer(s) leading their teams.
Leo Lou, Xueyan Jiang, Christine Chen, Dong Wu